Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples